SCHEMBL3323903

SCHEMBL3323903

O=C(COCc1ccco1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.58
POLB P06746 3/20 0.58
HSD11B1 P28845 3/20 0.55
TSHR P16473 4/20 0.55
GAA P10253 2/20 0.55
MAPK1 P28482 1/20 0.55
EPHX2 P34913 1/20 0.49
HSP90AA1 P07900 2/20 0.49
ALDH1A1 P00352 4/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3323180 0.78 HSD11B1 (0.56) KMT2AHSD11B1GAAHSP90AA1ALDH1A1
SCHEMBL13333324 0.76 HSD11B1 (0.58) KMT2APOLBHSD11B1GAAHSP90AA1
SCHEMBL3323361 0.76 POLB (0.58) KMT2APOLBHSD11B1TSHRGAA
SCHEMBL3324604 0.74 POLB (0.55) KMT2APOLBHSD11B1TSHRGAA
SCHEMBL3323437 0.74 POLB (0.61) KMT2APOLBTSHRGAAMAPK1
SCHEMBL13333042 0.73 POLB (1.00) KMT2APOLBHSD11B1TSHRGAA
SCHEMBL3323197 0.73 HSD11B1 (0.72) KMT2AHSD11B1GAAHSP90AA1ALDH1A1
SCHEMBL3321257 0.73 HSD11B1 (0.64) KMT2APOLBHSD11B1GAAEPHX2
SCHEMBL8555718 0.73 ALDH1A1 (0.56) KMT2APOLBTSHRGAAMAPK1
SCHEMBL3320789 0.72 HSD11B1 (0.67) KMT2AHSD11B1GAAMAPK1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120789-A1 Compound STERIX LIMITED (GB) 2010-05-13 US disclosed
EP-1861384-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2007-12-05 EP disclosed
WO-2006100502-A1 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS STERIX LIMITED (GB) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120789-A1 Compound NR0B2, NR0B1, NR4A1 KMT2A 2533/4885POLB 3372/4885HSD11B1 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.